ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,262Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 308

$2.34M Total Retail Price of All Prescriptions

Rank: 1 out of 308

692 Patients Receiving at Least One Drug in Part D
27%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 692 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

5% of this provider’s 2,715 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$164 was the average price of a prescription from this provider, compared to $135 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
ABILIFY 851 136 1 4
ZOLPIDEM TARTRATE 819 131 2 13
ZIPRASIDONE HCL 681 67 10 3 24
RISPERIDONE 642 234 4 1
TRAZODONE HCL 568 54 5 3
SERTRALINE HCL 534 125 6 5
MIRTAZAPINE 503 126 7 17
LAMOTRIGINE 497 123 8 6
QUETIAPINE FUMARATE 476 82 9 2
DIVALPROEX SODIUM ER 357 53 10 16
BUSPIRONE HCL 351 31 11 22
OLANZAPINE 321 49 12 10
BENZTROPINE MESYLATE 312 81 R 13 7
PRISTIQ ER 304 52 14 52
GEODON 295 30 10 15 45
VENLAFAXINE HCL ER 292 38 16 12
PAROXETINE HCL 289 50 17 19
LYRICA 289 39 17 72
ZONISAMIDE 283 31 19 71
ESCITALOPRAM OXALATE 273 66 20 27
DIVALPROEX SODIUM 269 80 21 23
FLUOXETINE HCL 236 14 22 8
BUPROPION XL 214 33 23 18
SEROQUEL 213 30 24 20
GABAPENTIN 174 0 25 28
LITHIUM CARBONATE 164 34 26 15
AMANTADINE 154 23 27 66
CYMBALTA 142 14 28 14
HALOPERIDOL 142 81 28 25
DONEPEZIL HCL 137 107 30 39
TOPIRAMATE 128 0 31 31
BUPROPION HCL SR 125 0 32 21
NAMENDA 124 104 33 36
SAVELLA 117 24 34 98
CARBAMAZEPINE 108 20 35 37
LEXAPRO 106 14 36 62
LUNESTA 101 0 37 59
SAPHRIS 101 16 37 74
AMPHETAMINE SALT COMBO 99 0 S2 39 29
SEROQUEL XR 98 12 40 41
THIOTHIXENE 86 42 41 44
CITALOPRAM HBR 75 11 42 9
METHYLPHENIDATE HCL 68 0 43 38
OXCARBAZEPINE 66 0 44 53
OLANZAPINE ODT 64 50 45 54
CYCLOBENZAPRINE HCL 61 0 R 46 91
VIIBRYD 60 0 47 84
LATUDA 54 0 48 55
IMIPRAMINE HCL 50 36 R 49 87
CLOZAPINE 50 0 49 11
AMITRIPTYLINE HCL 50 23 R 49 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 18, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.